Display options
Cite
Echenique IA, Nelson GE, Stosor V, et al. HIV and Stem Cell Transplantation. Curr Infect Dis Rep. 2014;16(9):424doi: 10.1007/s11908-014-0424-y.
Echenique, I. A., Nelson, G. E., Stosor, V., & Durand, C. M. (2014). HIV and Stem Cell Transplantation. Current infectious disease reports, 16(9), 424. https://doi.org/10.1007/s11908-014-0424-y
Echenique, Ignacio A, et al. "HIV and Stem Cell Transplantation." Current infectious disease reports vol. 16,9 (2014): 424. doi: https://doi.org/10.1007/s11908-014-0424-y
Echenique IA, Nelson GE, Stosor V, Durand CM. HIV and Stem Cell Transplantation. Curr Infect Dis Rep. 2014 Sep;16(9):424. doi: 10.1007/s11908-014-0424-y. PMID: 25120135.
Copy Download .nbib Format: NLM
Share it on

Curr Infect Dis Rep. 2014 Sep;16(9):424. doi: 10.1007/s11908-014-0424-y.

HIV and Stem Cell Transplantation.

Current infectious disease reports

Ignacio A Echenique, George E Nelson, Valentina Stosor, Christine M Durand

Affiliations

  1. Division of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave, Suite 900, Chicago, IL, 60611, USA, [email protected].

PMID: 25120135 DOI: 10.1007/s11908-014-0424-y

Abstract

In human immunodeficiency virus (HIV)-infected persons, the incidence of hematologic malignancies, including leukemia and lymphoma, is increased despite the use of successful antiretroviral therapy. Hematopoietic stem cell transplantation (SCT) is emerging as a safe and effective therapy for HIV-infected persons with hematologic malignancies. Management of these patients is complicated by drug-drug interactions involving antiretroviral therapy (ART) that may impact conditioning agent efficacy and metabolism of immunosuppressive medications and potentiate drug toxicities. As such, optimal strategies for ART remain controversial. We discuss recent advances, controversies, and future directions related to SCT in HIV-infected persons, including the investigation of allogeneic SCT as a strategy for HIV cure.

References

  1. N Engl J Med. 2004 Nov 25;351(22):2265-75 - PubMed
  2. N Engl J Med. 2013 Jan 17;368(3):218-30 - PubMed
  3. AIDS. 2011 Jan 14;25(2):273-4 - PubMed
  4. N Engl J Med. 2012 Jul 12;367(2):135-45 - PubMed
  5. Haematologica. 1990 May-Jun;75(3):285-7 - PubMed
  6. J Natl Cancer Inst. 2011 May 4;103(9):753-62 - PubMed
  7. N Engl J Med. 1997 Jun 5;336(23):1641-8 - PubMed
  8. N Engl J Med. 2009 Apr 30;360(18):1815-26 - PubMed
  9. Biol Blood Marrow Transplant. 2008 May;14(5):601-2 - PubMed
  10. J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22 - PubMed
  11. J Natl Cancer Inst. 2013 Aug 21;105(16):1221-9 - PubMed
  12. Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1069-78 - PubMed
  13. Science. 1996 Jun 28;272(5270):1955-8 - PubMed
  14. Science. 1997 Nov 14;278(5341):1291-5 - PubMed
  15. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7 - PubMed
  16. N Engl J Med. 2009 Feb 12;360(7):692-8 - PubMed
  17. Blood. 2002 Jan 15;99(2):698-701 - PubMed
  18. Blood. 2008 Oct 15;112(8):3484-7 - PubMed
  19. J Clin Oncol. 2009 Feb 20;27(6):884-90 - PubMed
  20. Clin Infect Dis. 2010 May 15;50(10):1387-96 - PubMed
  21. AIDS. 2006 Aug 1;20(12):1645-54 - PubMed
  22. Clin Infect Dis. 2013 Sep;57(5):756-64 - PubMed
  23. AIDS. 2005 Dec 2;19(18):2174-5 - PubMed
  24. MMWR Recomm Rep. 2008 Dec 5;57(RR-10):1-12 - PubMed
  25. Cell. 1996 Jun 28;85(7):1149-58 - PubMed
  26. Haematologica. 2007 Apr;92(4):e56-8 - PubMed
  27. Immunity. 2012 Sep 21;37(3):377-88 - PubMed
  28. Blood. 2009 Jun 4;113(23):5737-42 - PubMed
  29. AIDS. 2012 Jun 19;26(10):1311-8 - PubMed
  30. Blood. 2011 Jun 9;117(23):6100-8 - PubMed
  31. PLoS Pathog. 2013;9(5):e1003347 - PubMed
  32. Biol Blood Marrow Transplant. 2010 Sep;16(9):1302-8 - PubMed
  33. Cancer. 2000 Aug 1;89(3):680-9 - PubMed
  34. Antivir Ther. 2013;18(5):699-707 - PubMed
  35. N Engl J Med. 2010 Nov 18;363(21):2004-14 - PubMed
  36. Bone Marrow Transplant. 2010 Mar;45(3):584-6 - PubMed
  37. Br J Cancer. 2009 Mar 10;100(5):840-7 - PubMed
  38. J Clin Oncol. 2009 May 1;27(13):2192-8 - PubMed
  39. Cell. 1996 Jun 28;85(7):1135-48 - PubMed
  40. Am J Hematol. 2012 Mar;87(3):330-3 - PubMed
  41. JAMA. 2011 Apr 13;305(14):1450-9 - PubMed
  42. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9 - PubMed
  43. AIDS. 2011 Mar 13;25(5):691-700 - PubMed
  44. AIDS. 2001 Aug 17;15(12):1483-91 - PubMed
  45. Lancet. 1986 Mar 15;1(8481):575-80 - PubMed
  46. J Clin Oncol. 2003 Dec 1;21(23):4423-7 - PubMed
  47. Cancer. 2001 Jan 1;91(1):155-63 - PubMed
  48. AIDS. 2007 Mar 30;21(6):776-7 - PubMed
  49. N Engl J Med. 2006 Nov 30;355(22):2283-96 - PubMed
  50. Clin Exp Immunol. 2011 Mar;163(3):284-95 - PubMed
  51. Blood. 2005 Jan 15;105(2):874-8 - PubMed
  52. Liver Transpl. 2010 Apr;16(4):530-2 - PubMed
  53. Sci Transl Med. 2010 Jun 16;2(36):36ra43 - PubMed
  54. Science. 1997 Nov 14;278(5341):1295-300 - PubMed
  55. J Paediatr Child Health. 1992 Aug;28(4):331-3 - PubMed
  56. Nat Biotechnol. 2010 Aug;28(8):839-47 - PubMed
  57. Exp Hematol. 2005 Apr;33(4):487-94 - PubMed
  58. Biol Blood Marrow Transplant. 2009 Jul;15(7):864-71 - PubMed
  59. Cell. 1996 Aug 9;86(3):367-77 - PubMed
  60. J Infect Dis. 2012 Jul 1;206(1):28-34 - PubMed
  61. Am J Transplant. 2009 Aug;9(8):1946-52 - PubMed
  62. Clin Infect Dis. 2014 Jun;58(11):1599-606 - PubMed
  63. Hum Gene Ther. 2004 Mar;15(3):251-62 - PubMed
  64. Ann Intern Med. 1990 Oct 1;113(7):512-9 - PubMed
  65. Blood. 2009 Jun 4;113(23):6011-4 - PubMed
  66. Cancer. 2011 Mar 1;117(5):1089-96 - PubMed
  67. Hum Gene Ther. 1996 Jun 20;7(10):1281-306 - PubMed
  68. Rare Tumors. 2011 Mar 30;3(1):e11 - PubMed
  69. Ann Intern Med. 1989 Dec 15;111(12):973-81 - PubMed
  70. Nat Med. 2009 Mar;15(3):285-92 - PubMed
  71. Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):274-81 - PubMed
  72. N Engl J Med. 1983 Sep 15;309(11):665 - PubMed
  73. HIV Med. 2007 Mar;8(2):96-104 - PubMed
  74. Br J Haematol. 2009 Oct;147(2):246-61 - PubMed
  75. Ann Intern Med. 2008 May 20;148(10):728-36 - PubMed
  76. J Clin Oncol. 2005 Feb 20;23(6):1328-9; author reply 1329-30 - PubMed
  77. Haematologica. 2004 Sep;89(9):1100-8 - PubMed
  78. Clin Infect Dis. 2014 May;58(9):1312-21 - PubMed
  79. Liver Transpl. 2012 Jun;18(6):716-26 - PubMed
  80. Clin Infect Dis. 2010 Jun 15;50(12):1672-9 - PubMed
  81. Nature. 1996 Jun 20;381(6584):661-6 - PubMed
  82. Exp Hematol. 2002 Mar;30(3):279-84 - PubMed
  83. J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30 - PubMed
  84. N Engl J Med. 2011 Feb 17;364(7):683; author reply 684 - PubMed
  85. Trends Immunol. 2012 Nov;33(11):554-62 - PubMed
  86. J Infect Dis. 2013 Jun 1;207(11):1694-702 - PubMed
  87. AIDS. 1991 Mar;5(3):344 - PubMed
  88. Am J Transplant. 2005 Feb;5(2):207-17 - PubMed
  89. J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):438-41 - PubMed
  90. Haematologica. 1992 May-Jun;77(3):287-90 - PubMed
  91. J Antimicrob Chemother. 2013 Apr;68(4):972-4 - PubMed
  92. J Clin Oncol. 2003 Sep 15;21(18):3447-53 - PubMed
  93. HIV Med. 2011 Sep;12(8):481-6 - PubMed
  94. PLoS One. 2013 Jul 18;8(7):e69266 - PubMed
  95. AIDS. 2013 Sep 24;27(15):2365-73 - PubMed
  96. Lancet. 2012 Jul 21;380(9838):203-4 - PubMed
  97. J Antimicrob Chemother. 2013 May;68(5):1169-78 - PubMed
  98. Cancer. 2010 Dec 1;116(23):5507-16 - PubMed
  99. Nature. 1996 Jun 20;381(6584):667-73 - PubMed
  100. N Engl J Med. 1984 Oct 25;311(17):1099-103 - PubMed
  101. Biol Blood Marrow Transplant. 2008 Jan;14(1):59-66 - PubMed
  102. N Engl J Med. 2004 Nov 25;351(22):2276-85 - PubMed
  103. Nat Med. 2010 Apr;16(4):446-51 - PubMed
  104. Am J Transplant. 2007 Dec;7(12):2816-20 - PubMed
  105. Bone Marrow Transplant. 2005 Aug;36(3):261-2 - PubMed

Publication Types